-
The Application of Clinical Genetics
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
The Application of Clinical Genetics
Editorial
(932) Views (175) Full article downloads
Authors: Maurer MH
Published Date February 2012
Volume 2012:5 Pages 19 - 20
DOI: http://dx.doi.org/10.2147/TACG.S30150
Martin H MaurerDepartment of Physiology and Pathophysiology, University of Heidelberg, Heidelberg, Germany; Mariaberg Hospital for Child and Adolescent Psychiatry, Gammertingen, Germany
In 2012, The Application of Clinical Genetics enters its fifth year of publication. The journal has had a change of Editor-in-Chief: Dr David H Tegay stepped down and I was appointed to serve as the new Editor-in-Chief. As his successor, I thank Dr Tegay for his great work for the journal. I hope I can continue his successful editorial contributions. Moreover, I thank the many reviewers for their sustained support of the journal.
The Application of Clinical Genetics is dedicated to open access publishing – as all Dove Press journals are. This means that authors will be charged for the publication process, but the acceptance of a manuscript is based solely on its scientific quality. This is what I will be responsible for as Editor-in-Chief. The team at Dove Press is a constant help with all administrative duties concerning peer reviewal, and I want to express my thanks for their prompt and reliable help.
The field of clinical genetics is facing new challenges with the broad availability of large-scale screening methods for gene mutations, such as high-throughput sequencing and biochips. This means that ethical issues regarding the handling of genetic information must be addressed, both for the individual and for society.1–3 For example, sequencing of cell-free, fetal nucleic acids in the maternal blood to locate fetal aneuploidy, especially trisomy 21, may become broadly available soon, with even faster results than conventional methods such as amniocentesis.
Readers of this article also read:
Gene polymorphisms in association with self-reported stroke in US adults
Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors
Disorders caused by chromosome abnormalities
Alpha1-antitrypsin deficiency: a clinical-genetic overview
Genetic basis of Parkinson's disease: inheritance, penetrance, and expression
Advances in the production of human monoclonal antibodies
The role of genetics in pre-eclampsia and potential pharmacogenomic interventions
Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era
Chronic lymphocytic leukemia-associated chromosomal abnormalities and miRNA deregulation
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- DataGenno: building a new tool to bridge molecular and clinical genetics
- Congenital malformations in Ecuadorian children: urgent need to create a National Registry of Birth Defects
- Epigenetic modifications of embryonic stem cells: current trends and relevance in developing regenerative medicine
- Stem cell horizons in intervertebral disc degeneration




